UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 665

Sortiert nach

1-Deoxysphingolipids

Biochimica et biophysica acta. Molecular and cell biology of lipids, 2019-04, Vol.1864 (4), p.512-521

2019

Volltextzugriff (PDF)

Mammalian sphingoid bases: Biophysical, physiological and pathological properties

Progress in lipid research, 2019-07, Vol.75, p.100988-100988, Article 100988

2019

Volltextzugriff (PDF)

Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus

PloS one, 2017-05, Vol.12 (5), p.e0175776-e0175776

2017

Volltextzugriff (PDF)

Synthesis and characterization of some atypical sphingoid bases

Bioorganic & medicinal chemistry, 2018-08, Vol.26 (14), p.4047-4057

2018

Volltextzugriff (PDF)

Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

Diabetologia, 2012-02, Vol.55 (2), p.421-431

2012

Volltextzugriff (PDF)

Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?

European journal of neurology, 2015-05, Vol.22 (5), p.806-e55

2015

Volltextzugriff (PDF)

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus

PloS one, 2017-06, Vol.12 (6), p.e0179313-e0179313

2017

Volltextzugriff (PDF)

Metabolic indicators of an altered sphingolipid metabolism are biomarkers for non-alcoholic fatty liver disease

Atherosclerosis, 2023-08, Vol.379, p.S30

2023

Volltextzugriff (PDF)

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Acta diabetologica, 2021-03, Vol.58 (3), p.319-327

2021

Volltextzugriff (PDF)

Mammalian sphingoid bases: Biophysical, physiological and pathological properties

Progress in lipid research, 2019-08, p.100995-100995, Article 100995

2019

Volltextzugriff (PDF)

Metabolic indicators of an altered sphingolipid metabolism are biomarkers for non-alcoholic fatty liver disease

Atherosclerosis, 2022-08, Vol.355, p.166

2022

Volltextzugriff (PDF)

C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages

Cell death & disease, 2012-03, Vol.3 (3), p.e280-e280

2012

Volltextzugriff (PDF)

MOTOR NEURON DISORDERS AND NEUROPATHIES: EP.245 Characterization of a novel form of ALS associated with changes in the sphingolipid metabolism

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S123-S123

2021

Volltextzugriff (PDF)

MOTOR NEURON DISORDERS AND NEUROPATHIES

Neuromuscular disorders : NMD, 2021-10, Vol.31, p.S123

2021

Volltextzugriff (PDF)

Sphingolipids and deoxysphingolipids in diabetes

Atherosclerosis, 2016-12, Vol.255, p.4-4

2016

Volltextzugriff (PDF)

Plasma sphingolipid profiling reveals novel distinct biomarkers for predicting cardiovascular disease and type 2 diabetes mellitus

Atherosclerosis, 2014-08, Vol.235 (2), p.e16-e16

2014

Volltextzugriff (PDF)

Hereditory Sensory Neuropathy Type 1 ( SPTLC1 ): phenotypic variation in patients with the English founder mutation

Neuromuscular disorders : NMD, 2017-03, Vol.27, p.S26-S27

2017

Volltextzugriff (PDF)

Apolipoprotein m modulates erythrocyte efflux and urinary excretion of sphingosine-1-phosphate

Atherosclerosis, 2014-08, Vol.235 (2), p.e176-e176

2014

Volltextzugriff (PDF)

Low concentrations of sphingosine-1-phosphates and plasmalogens in HDL are associated with coronary artery disease and reduced anti-apoptotic activity of HDL

Atherosclerosis, 2014-08, Vol.235 (2), p.e46-e46

2014

Volltextzugriff (PDF)

FADS3 is a Δ14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome

The Journal of biological chemistry, 2020-02, Vol.295 (7), p.1889-1897

2020

Volltextzugriff (PDF)

P53 Identifying responsive outcome measures in hereditary sensory neuropathy type 1 (HSN1)

Neuromuscular disorders : NMD, 2014-03, Vol.24, p.S21-S21

2014

Volltextzugriff (PDF)

Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology

BioFactors (Oxford), 1998, Vol.8 (3-4), p.229-234

1998

Volltextzugriff (PDF)

P42 Hereditary sensory neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases

Neuromuscular disorders : NMD, 2012-03, Vol.22, p.S18-S18

2012

Volltextzugriff (PDF)

Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

Diabetologia, 2012-02, Vol.55 (2), p.421-431

2012

Volltextzugriff (PDF)

P46 Clinical and genetic characterisation of hereditary sensory neuropathy type 1 caused by mutations in SPTLC2

Neuromuscular disorders : NMD, 2012-03, Vol.22, p.S19-S19

2012

Volltextzugriff (PDF)

1 – 25 von 665

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(619)
Mit Volltextzugriff
(606)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(428)
Life Sciences & Biomedicine
(339)
Humans
(255)
Female
(146)
Animals
(104)
Male
(102)
Middle Aged
(97)
Adult
(90)
Mice
(74)
Biochemistry & Molecular Biology
(69)
Physical Sciences
(64)
Aged
(59)
Medicine
(56)
Proteins
(56)
Medicine & Public Health
(55)
Obstetrics & Gynecology
(49)
Chemistry
(44)
Lipids
(44)
Neurosciences & Neurology
(40)
Science & Technology - Other Topics
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

1-Deoxysphingolipids

Mammalian sphingoid bases: Biophysical, physiological and pathological properties

Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus

Synthesis and characterization of some atypical sphingoid bases

Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

Elevation of plasma 1-deoxy-sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?

Correction: Plasma 1-deoxysphingolipids are early predictors of incident type 2 diabetes mellitus

Metabolic indicators of an altered sphingolipid metabolism are biomarkers for non-alcoholic fatty liver disease

Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver disease

Mammalian sphingoid bases: Biophysical, physiological and pathological properties

Metabolic indicators of an altered sphingolipid metabolism are biomarkers for non-alcoholic fatty liver disease

C16 ceramide is crucial for triacylglycerol-induced apoptosis in macrophages

MOTOR NEURON DISORDERS AND NEUROPATHIES: EP.245 Characterization of a novel form of ALS associated with changes in the sphingolipid metabolism

MOTOR NEURON DISORDERS AND NEUROPATHIES

Sphingolipids and deoxysphingolipids in diabetes

Plasma sphingolipid profiling reveals novel distinct biomarkers for predicting cardiovascular disease and type 2 diabetes mellitus

Hereditory Sensory Neuropathy Type 1 ( SPTLC1 ): phenotypic variation in patients with the English founder mutation

Apolipoprotein m modulates erythrocyte efflux and urinary excretion of sphingosine-1-phosphate

Low concentrations of sphingosine-1-phosphates and plasmalogens in HDL are associated with coronary artery disease and reduced anti-apoptotic activity of HDL

FADS3 is a Δ14Z sphingoid base desaturase that contributes to gender differences in the human plasma sphingolipidome

P53 Identifying responsive outcome measures in hereditary sensory neuropathy type 1 (HSN1)

Some new aspects of creatine kinase (CK): compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology

P42 Hereditary sensory neuropathy type 1: correlation of severity and plasma atypical deoxy-sphyngoid bases

Plasma deoxysphingolipids: a novel class of biomarkers for the metabolic syndrome?

P46 Clinical and genetic characterisation of hereditary sensory neuropathy type 1 caused by mutations in SPTLC2

Suchergebnisse filtern